Search results for "Mass Screening"

showing 10 items of 187 documents

Entwicklung eines ICF-basierten Leitfadens für die Beurteilung funktioneller Aspekte bei Kopf-Hals-Tumoren

2013

Funktionelle Beeintrachtigungen bei Kopf-Hals-Tumoren werden bisher im klinischen Alltag selten standardisiert erhoben. Klinische Studien mit der Zielgrose Funktionserhalt bei KHT verwenden viele verschiedene Instrumente. Die Ergebnisse sind deshalb oft schlecht vergleichbar und lassen zu wenig klinische Schlussfolgerungen zu. Es war daher notwendig und Ziel dieser Studie, die nach bisheriger Evidenz und interdisziplinarem Expertenkonsens am besten geeigneten Instrumente zur Beurteilung von Funktionsfahigkeit bei KHT zu identifizieren und Empfehlungen fur deren Verwendung in einem Leitfaden zusammenzustellen. In Vorstudien wurde unter Verwendung festgelegter Kriterien eine Vorauswahl an Ins…

Gynecologymedicine.medical_specialtyPediatricsSocial adjustmentbusiness.industryOutcome measuresGuidelineOutcome assessmentClinical PracticeOtorhinolaryngologymedicineInterdisciplinary communicationCooperative behaviorbusinessMass screeningLaryngo-Rhino-Otologie
researchProduct

Komorbide Internetsucht unter Patienten der stationären Suchtrehabilitation: Eine explorative Erhebung zur klinischen Prävalenz

2012

Anliegen: Die exzessive Nutzung des Internets wird als substanzungebundene Form einer Abhangigkeitserkrankung diskutiert. Laut Pravalenzschatzungen ist 1 % der deutschen Bevolkerung betroffen. Ungeklart ist, inwieweit Internetsucht komorbid unter Patienten der stationaren Suchtrehabilitation auftritt. Methode: In 15 Kliniken wurden alle innerhalb eines halben Jahres aufgenommenen Patienten auf das Vorliegen von Internetsucht gescreent. Ergebnisse: 4,2 % der Patienten erfullten die Kriterien. Diese waren haufiger mannlich mit den Primardiagnosen Cannabisabhangigkeit und pathologisches Glucksspiel. Schlussfolgerungen: Dies verdeutlicht den Bedarf an entsprechenden Routinescreenings innerhalb …

Gynecologymedicine.medical_specialtyRehabilitationbusiness.industryAddictionmedia_common.quotation_subjectmedicine.medical_treatmentCo morbidPsychiatry and Mental healthRehabilitation facilityMulticenter studySex factorsmedicineCo morbiditybusinessMass screeningmedia_commonPsychiatrische Praxis
researchProduct

Early diagnosis of colorectal cancer. Diagnostic delay reduction or rather screening programs?

2006

Gynecologymedicine.medical_specialtyTime Factorsbusiness.industryGastroenterologyGeneral MedicinePrognosisUnited KingdomSurvival RatemedicineDisease ProgressionHumansMass Screeninglcsh:Diseases of the digestive system. Gastroenterologylcsh:RC799-869businessColorectal NeoplasmsRevista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva
researchProduct

ScreenPro FH - Screening project for familial hypercholesterolemia in central, southern and eastern Europe: Rationale and design

2017

Familial hypercholesterolemia (FH) is a genetic disorder with well-known genetic transmission and clinical course. Despite great recent progress, FH is still underestimated, under-diagnosed and thus undertreated. Furthermore it represents a significant healthcare challenge as a common risk factor for the premature development of coronary heart disease. The ScreenPro FH Project is an international network project aiming at improving complex care - from timely screening, through diagnosis to up-to-date treatment of familial hypercholesterolemia in Central, Eastern and Southern Europe. An important task for the project is to harmonise and unify diagnostic and therapeutic approaches in particip…

Gynecologymedicine.medical_specialtybusiness.industryAnticholesteremic AgentsCoronary DiseaseFamilial hypercholesterolemia030204 cardiovascular system & hematologymedicine.disease3. Good healthEuropeHyperlipoproteinemia Type II03 medical and health sciences0302 clinical medicineRisk FactorsInternal MedicinemedicinePhysical therapyBlood Component RemovalHumansMass Screening030212 general & internal medicineEurope EasternCardiology and Cardiovascular Medicinebusiness
researchProduct

Viral hepatitis in 2021: The challenges remaining and how we should tackle them

2022

Viral hepatitis results in 1.4 million deaths annually. The World Health Organization (WHO) set an ambitious target to eliminate viral hepatitis by 2030, but significant challenges remain. These include inequalities in access to healthcare, reaching at risk populations and providing access to screening and effective treatment. Stigma around viral hepatitis persists and must be addressed. The WHO goal of global elimination by 2030 is a worthy aim, but remains ambitious and the coronavirus 2019 pandemic undoubtedly has set back progress. This review article will focus on hepatitis A to E, highlighting problems that have been resolved in the field over the past decade, those that remain to be …

Hepatitis Viral HumanGastroenterologyCOVID-19ReviewGeneral MedicineHepatitis AHepatitis BGlobal HealthWorld Health OrganizationHepatitis CAntiviral AgentsHepatitis DHepatitis EHumansMass ScreeningWorld Journal of Gastroenterology
researchProduct

Opportunistic co-screening for HCV and COVID-19-related services: A creative response with a need for thoughtful reflection.

2022

At a time when hepatitis C virus clearance can be obtained by DAAs in almost all infected patients, global infection burden control is an objective within reach, even if achieving the WHO HCV elimination targets by 2030 may not be attainable. 1 The lowest cost intervention is an awareness campaign to bring in those who are recently diagnosed and those who were previously diagnosed but not treated. Only 30% of all HCV‐diagnosed patients are linked‐to‐care. 2 The next level of intervention is case‐finding for disease control and screening. Screening invites people who do not have symptoms to undergo testing, whereas health professionals are focused on detecting conditions as early as possible…

HepatologyScreeningCOVID-19HumansMass ScreeningHIV InfectionsHepatitis CLiver international : official journal of the International Association for the Study of the Liver
researchProduct

Is large-scale rapid CoV-2 testing a substitute for lockdowns?

2021

Background Various forms of contact restrictions have been adopted in response to the Covid-19 pandemic. Around February 2021, rapid testing appeared as a new policy instrument. Some claim it may serve as a substitute for contact restrictions. We study the strength of this argument by evaluating the effects of a unique policy experiment: In March and April 2021, the city of Tübingen set up a testing scheme while relaxing contact restrictions. Methods We compare case rates in Tübingen county to an appropriately identified control unit. We employ the synthetic control method. We base interpretations of our findings on an extended SEIR model. Findings The experiment led to an increase in the …

History2019-20 coronavirus outbreakPolymers and PlasticsCoronavirus disease 2019 (COVID-19)Computer scienceSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)610 MedizinDeclarationIndustrial and Manufacturing EngineeringCOVID-19 TestingArgument610 Medical sciencesGermany320 Political scienceEconometricsHumansMass ScreeningBusiness and International ManagementRapid testingActuarial scienceMultidisciplinary330 WirtschaftState governmentCOVID-19330 EconomicsScale (social sciences)Quarantine320 PolitikControl methodsPloS one
researchProduct

The Primary Care Evaluation of Mental Disorders (PRIME-MD), German version: a comparison with the CIDI

2000

There is a need for the development and evaluation of diagnostic instruments suitable for daily use in primary care offices that can improve recognition rates of psychopathology. The objective of this study is the comparison of the German version of the Primary Care Evaluation of Mental Disorders (PRIME-MD), a short structured diagnostic instrument, with the Composite International Diagnostic Interview (CIDI) and to gather some information on the usefulness of the PRIME-MD. Seven hundred and four patients were assessed three times, once using the physician's clinical judgement, subsequently, administering the PRIME-MD, DSM-IV version and finally, with the CIDI. The CIDI was administered on …

Hospitals PsychiatricMalemedicine.medical_specialtyPsychometricsPsychometricsTest validitySensitivity and SpecificityPredictive Value of TestsGermanyHumansMass ScreeningMedicinePsychiatryBiological PsychiatryPsychiatric Status Rating ScalesPrimary Health Carebusiness.industryMental Disordersmedicine.diseaseCIDIPsychiatry and Mental healthEating disordersMood disordersStructured interviewAnxietyFemalemedicine.symptombusinessPsychopathologyClinical psychologyJournal of Psychiatric Research
researchProduct

Clinical Use of κ Free Light Chains Index as a Screening Test for Multiple Sclerosis.

2020

Abstract Objective To assess the usefulness of the κ free light chain index (κFLCi) as a screening test to identify patients with suspected MS. Methods The study included 56 patients with a request to test for oligoclonal bands (OCBs). OCBs were detected by isoelectric focusing, followed by immunofixation. Cerebrospinal fluid (CSF) and serum κFLC were measured by a turbidimetric assay. Also, the κFLC index (κFLCi) was calculated. Results CSF κFLC levels and κFLCi were significantly higher in patients with multiple sclerosis (MS) than in patients with other neurological diseases (NDs; P < .001 and P < .001, respectively). At the cutoff value of 2.9, the κFLCi detected MS with s…

ImmunofixationAdultMale030213 general clinical medicinemedicine.medical_specialtyMultiple SclerosisScreening testClinical BiochemistryκFLCCSFfree light chainImmunoglobulin light chainGastroenterologySensitivity and Specificity03 medical and health sciences0302 clinical medicineCerebrospinal fluidInternal medicinemedicineHumansMass ScreeningAgedOCBbiologybusiness.industryIsoelectric focusingMultiple sclerosisBiochemistry (medical)Middle AgedκFLC indexmedicine.diseaseFree Light Chainmultiple sclerosibiology.proteinbiomarkerBiomarker (medicine)FemaleImmunoglobulin Light Chainsbusiness030217 neurology & neurosurgeryBiomarkersLaboratory medicine
researchProduct

Orally based diagnosis of celiac disease:current perspective

2008

Celiac disease (CD) is a lifelong immune-mediated disorder caused by the ingestion of wheat gluten in genetically susceptible persons. Most cases of CD are atypical and remain undiagnosed, which exposes the individuals to the risk of life-threatening complications. Serologic endomysial and tissue transglutaminase antibody tests are used to screen at-risk individuals, although a firm diagnosis requires demonstration of characteristic histopathologic findings in the small-intestinal mucosa. A gluten challenge, with a repeat biopsy to demonstrate recurrence of histopathologic changes in the intestinal mucosa after the re-introduction of gluten, is considered for those persons in whom diagnosi…

Immunoglobulin Aceliac disease diagnosis oral mucosa saliva screeningmedicine.medical_specialtySalivaGlutensDiseaseGastroenterologyAntibodiesSerologyIntestinal mucosaInternal medicinemedicineHumansMass ScreeningOral mucosaSalivaGeneral Dentistrychemistry.chemical_classificationbiologybusiness.industryMouth MucosaGlutenCeliac Diseasemedicine.anatomical_structurechemistryImmunoglobulin A SecretoryImmunologybiology.proteinAntibodybusiness
researchProduct